Post A Reply

Rate Intersect ENT

  • Culture

  • Compensation

  • Opportunity for advancement

  • Realistic plan attainment

×

Salaries

In our drive to help people in the medical sales industry we are gathering salary data. This information will be collated, analyzed and number crunched. Medtechy’s overall goal is to help the medical sales industry make more informed decisions when changing jobs and also keep employers and recruiters honest

Take 30 seconds and let us know your current deal.*

About The Position

Compensation

* We guarantee all data collected is completely anonymous and will only be used for the benefit of future visitors.

×

Hot Ticker Articles

TransEnterix sells first Senhance Robotic System to Florida Hospital. Is SurgiBot up Next?

What was a Surgeon's First Impression of the Senhance Robotic System?

Will New Stent Study Negatively Impact Boston Scientific and Medtronic?

Intersect ENT's Sinus Implant Proves Effective, But Is It Too Expensive?

Don't Overlook This Major Difference Between Intuitive Surgical and TransEnterix

Job Listings

Intersect ENT CONFIDENTIAL TREATMENT ORDER

Intersect ENT, Inc. submitted an application under Rule 406 requesting an extension of a previous grant of confidential treatment for information it excluded from the Exhibits to a Form S-1 registration statement filed on June 23, 2014, as amended.

What is XENT trying to hide?

Post A Reply

Report this entire thread

The reason we ask for your email address is to ensure the reporting feature is not abused. Once you report a thread a confirmation email will be sent to you requiring that you did in fact mean to do this action. This also gives us a way to get in touch with you privately to discuss your reasoning if we feel the thread has been reported without merit.

Your email address will never be used for any other reason and will never be sold to email marketers.

A reason is required.

JNJ has begged Intersect for years to buy Acclarent.

no they haven't.

post

Or growth in Intersect is dead and buy Entellus.....

JNJ has begged Intersect for years to buy Acclarent.

post

Bombshell coming. Sell your stock.

The confidential order was to protect their bid for Spirox.

post

Loading...


Report this post

The reason we ask for your email address is to ensure the reporting feature is not abused. Once you report a post a confirmation email will be sent to you requiring that you did in fact mean to do this action. This also gives us a way to get in touch with you privately to discuss your reasoning if we feel the post has been reported without merit.

Your email address will never be used for any other reason and will never be sold to email marketers.

A reason is required.